4
MARKET OVERVIEW
Summarizes the competitive environment, macro signals, and segment-level movements driving market outcomes.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN THE ASIA PACIFIC PROTEOMICS MARKET
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PROTEOMICS INSTRUMENTS (2022-2025)
5.5.2
AVERAGE SELLING PRICE TREND, BY COUNTRY (2022-2025)
5.6.1
IMPORT SCENARIO (HS CODE 902720 AND 902781)
5.6.2
EXPORT SCENARIO (HS CODE 902720 AND 902781)
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF – ASIA PACIFIC PROTEOMICS MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.3
PROTEIN MICROARRAYS
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
ADJACENT TECHNOLOGIES
6.3.1
SINGLE CELL PROTEOMICS
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON ASIA PACIFIC PROTEOMICS MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN THE ASIA PACIFIC PROTEOMICS MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE ASIA PACIFIC PROTEOMICS MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
ASIA PACIFIC PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2023-2030 (USD MILLION)
COMPARATIVE ASSESSMENT OF KEY PRODUCTS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
9.3.1
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
9.3.3
AFFINITY CHROMATOGRAPHY
9.3.4
SUPERCRITICAL FLUID CHROMATOGRAPHY
9.4.1
GEL ELECTROPHORESIS
9.4.2
CAPILLARY ELECTROPHORESIS
9.5.2
MICROARRAY INSTRUMENTS
9.5.2.1
INTEGRATED SYSTEMS
9.5.2.2
MICROARRAY SCANNERS
9.6
X-RAY CRYSTALLOGRAPHY
9.7
SURFACE PLASMON RESONANCE
9.8
PROTEIN FRACTIONATION
9.9
OTHER INSTRUMENTATION TECHNOLOGIES
10
ASIA PACIFIC PROTEOMICS MARKET, BY REAGENT, 2023-2030 (USD MILLION)
COMPARATIVE ASSESSMENT OF KEY TECHNIQUES, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
10.2
IMMUNOASSAY REAGENTS
10.3
SPECTROSCOPY REAGENTS
10.4
CHROMATOGRAPHY REAGENTS
10.5
PROTEIN MICROARRAY REAGENTS
10.6
X-RAY CRYSTALLOGRAPHY REAGENTS
10.7
ELECTROPHORESIS REAGENTS
10.8
PROTEIN FRACTIONATION REAGENTS
11
ASIA PACIFIC PROTEOMICS MARKET, BY SERVICE, 2023-2030 (USD MILLION)
COMPARATIVE ASSESSMENT OF KEY TYPES, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
11.2
CORE PROTEOMICS SERVICES
11.2.1
PROTEIN IDENTIFICATION SERVICES
11.2.2
QUANTITATIVE PROTEOMICS SERVICES
11.2.3
PROTEIN CHARACTERIZATION SERVICES
11.2.4
PROTEIN PURIFICATION SERVICES
11.2.5
PROTEIN SEPARATION SERVICES
11.2.6
PROTEIN SEQUENCING SERVICES
11.2.7
CUSTOM ASSAY SERVICES
11.3
BIOINFORMATICS SERVICES
12
ASIA PACIFIC PROTEOMICS MARKET, BY SOFTWARE, 2023-2030 (USD MILLION)
APPLICATION-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS PROTEOMICS ADOPTION
12.2
BIOINFORMATICS TOOLS
12.3
BIOINFORMATICS DATABASES
13
ASIA PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
13.2
CLINICAL DIAGNOSTICS
13.2.2
INFECTIOUS DISEASES
13.2.4
NEUROLOGICAL DISORDERS
13.2.5
AUTOIMMUNE DISEASES
13.2.6
CARDIOVASCULAR DISEASES
13.2.7
OTHER CLINICAL DIAGNOSTIC APPLICATIONS
13.3
DRUG DISCOVERY & DEVELOPMENT
13.3.2
LEAD IDENTIFICATION
13.3.4
PRECLINICAL STUDIES
14
ASIA PACIFIC PROTEOMICS MARKET, BY END USER, 2023-2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
14.2
BIOPHARMACEUTICAL COMPANIES
14.3
ACADEMIC & RESEARCH INSTITUTES
14.5
CLINICAL LABORATORIES
15
ASIA PACIFIC PROTEOMICS MARKET, BY REGION, 2023-2030 (USD MILLION)
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
15.2
6 REST OF ASIA PACIFIC
15.2.8
MACROECONOMIC OUTLOOK OF APAC
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
16.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
16.3
REVENUE ANALYSIS, 2022-2024
16.4
MARKET SHARE ANALYSIS,
16.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
16.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
16.5.5.1
COMPANY FOOTPRINT
16.5.5.2
REGION FOOTPRINT
16.5.5.3
PRODUCT FOOTPRINT
16.5.5.4
TECHNIQUE FOOTPRINT
16.5.5.5
APPLICATION FOOTPRINT
16.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
16.6.1
PROGRESSIVE COMPANIES
16.6.2
RESPONSIVE COMPANIES
16.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
16.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
16.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
16.7
COMPETITIVE SCENARIO
16.7.3
OTHER DEVELOPMENTS
16.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
16.9
VALUATION AND FINANCIAL METRICS
17.1.1
THERMO FISHER SCIENTIFIC INC (US)
17.1.2
DANAHER CORPORATION (US)
17.1.3
AGILENT TECHNOLOGIES (US)
17.1.4
BRUKERS CORPORATION (US)
17.1.5
SHIMADZU CORPORATION (JAPAN)
17.1.6
BIO RAD LABORATORIES INC. (US)
17.1.7
WATERS COPRORATION (US)
17.1.8
QIAGEN (NETHERLANDS)
18.1.1.1
KEY SOURCES OF SECONDARY DATA
18.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
18.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
18.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
18.2
MARKET SIZE ESTIMATION
18.2.1
ASIA PACIFIC PROTEOMICS MARKET SIZE ESTIMATION
18.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
18.2.1.2
MNM REPOSITORY ANALYSIS
18.2.1.3
SECONDARY ANALYSIS
18.2.1.4
PRIMARY RESEARCH
18.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
17.3
MARKET GROWTH RATE PROJECTIONS
17.6
RESEARCH ASSUMPTIONS
17.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
19.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
AVAILABLE CUSTOMIZATIONS
Growth opportunities and latent adjacency in Asia Pacific Proteomics Market